NHS Approves First Major Stomach Cancer Advance in a Decade

A new immunotherapy drug for aggressive stomach cancer just got the green light from the NHS, marking the first major treatment breakthrough in nearly ten years.

About 1,500 people a year in the UK will now have access to a therapy that extends survival and reduces cancer recurrence.